Journal of Nuclear Medicine March 2026, jnumed.125.271031; DOI: https://doi.org/10.2967/jnumed.125.271031 ...
Journal of Nuclear Medicine February 2026, jnumed.125.270083; DOI: https://doi.org/10.2967/jnumed.125.270083 ...
Journal of Nuclear Medicine February 2026, jnumed.125.271410; DOI: https://doi.org/10.2967/jnumed.125.271410 ...
Journal of Nuclear Medicine January 2026, jnumed.125.271452; DOI: https://doi.org/10.2967/jnumed.125.271452 ...
Journal of Nuclear Medicine December 2025, jnumed.125.270770; DOI: https://doi.org/10.2967/jnumed.125.270770 ...
Journal of Nuclear Medicine December 2025, jnumed.125.271103; DOI: https://doi.org/10.2967/jnumed.125.271103 ...
Radiotheranostics refers to dual diagnostic–therapeutic capacity that allows for precision medicine at an unprecedented level, reducing collateral toxicity and improving patient outcomes ([1][1]). In ...
Radioimmunotherapy using 225Ac, a highly cytotoxic α-particle emitter, has potential for treating advanced breast cancer, especially human epidermal growth factor receptor 2 (HER2)–positive cases. We ...
Journal of Nuclear Medicine October 2025, jnumed.125.271028; DOI: https://doi.org/10.2967/jnumed.125.271028 ...
Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...
Journal of Nuclear Medicine July 2025, jnumed.125.270252; DOI: https://doi.org/10.2967/jnumed.125.270252 ...
Journal of Nuclear Medicine July 2025, jnumed.125.269653; DOI: https://doi.org/10.2967/jnumed.125.269653 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results